Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12807192rdf:typepubmed:Citationlld:pubmed
pubmed-article:12807192lifeskim:mentionsumls-concept:C1206959lld:lifeskim
pubmed-article:12807192pubmed:issuePt 3lld:pubmed
pubmed-article:12807192pubmed:dateCreated2003-6-16lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:abstractTextStrain HAG 010767(T) was isolated from desert soil from Namibia during a screening programme. On the basis of analysis of 16S rDNA, the principal amino acid of the peptidoglycan, cell-wall sugars, fatty acids and polar lipids, it was possible to identify this strain as a member of the genus Actinomadura. Although DNA-DNA reassociation experiments revealed 72% DNA similarity between strain HAG 010767(T) and Actinomadura kijaniata DSM 43764(T), significant differences in the colour of the mycelium and physiological properties indicate that strain HAG 010767(T) represents a novel species of this genus, for which the name Actinomadura namibiensis sp. nov. is proposed. The type strain is strain HAG 010767(T) (= DSM 44197(T) = NRRL B-24153(T)).lld:pubmed
pubmed-article:12807192pubmed:languageenglld:pubmed
pubmed-article:12807192pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:citationSubsetIMlld:pubmed
pubmed-article:12807192pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12807192pubmed:statusMEDLINElld:pubmed
pubmed-article:12807192pubmed:monthMaylld:pubmed
pubmed-article:12807192pubmed:issn1466-5026lld:pubmed
pubmed-article:12807192pubmed:authorpubmed-author:KroppenstedtR...lld:pubmed
pubmed-article:12807192pubmed:authorpubmed-author:StackebrandtE...lld:pubmed
pubmed-article:12807192pubmed:authorpubmed-author:SeibertGerhar...lld:pubmed
pubmed-article:12807192pubmed:authorpubmed-author:WinkJoachimJlld:pubmed
pubmed-article:12807192pubmed:issnTypePrintlld:pubmed
pubmed-article:12807192pubmed:volume53lld:pubmed
pubmed-article:12807192pubmed:ownerNLMlld:pubmed
pubmed-article:12807192pubmed:authorsCompleteYlld:pubmed
pubmed-article:12807192pubmed:pagination721-4lld:pubmed
pubmed-article:12807192pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:meshHeadingpubmed-meshheading:12807192...lld:pubmed
pubmed-article:12807192pubmed:year2003lld:pubmed
pubmed-article:12807192pubmed:articleTitleActinomadura namibiensis sp. nov.lld:pubmed
pubmed-article:12807192pubmed:affiliationAventis Pharma Deutschland, Drug Innovation and Approval, Natural Products, 65926 Frankfurt, Germany. Joachim.Wink@aventis.comlld:pubmed
pubmed-article:12807192pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12807192pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12807192pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:12807192pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed